Position Statement on Use of Pathogen‐Reduced Cryoprecipitate in Settings Where Commercial Clotting Factor Concentrates are Unavailable or Unaffordable
9 July 2009
| Position paper
WHO Team
Blood and other Products of Human Origin (BTT)
Number of pages
5